PATENT CLAIM ANALYSIS

Application Number: 15976800
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "224200"]

Abstract:
Disclosed herein are compositions comprising a drug such as a triptan (e.g. rizatriptan) and/or an NSAID (e.g. meloxicam) in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the drug for the treatment of conditions such as pain.

Claim (Index 52):
The method of  claim 45 , wherein the SBE\u03b2CD has about 6 to about 7 sulfobutyl ether groups for each molecule of \u03b2-cyclodextrin.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 93.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15936176', '15902770', '15797955', '15132130', '12608445']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7839482829453233
- 35 USC 102 Novelty (BERT): 0.5937320959113889
- Combined Prediction Score: 0.7649266642419299
- Mean Citation Score: 354.25
- Max Citation Score: 497.04276
- Similarity Product: 464.4540082590509

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test